Kontour (Xi'an) Medical Technology Co., Ltd. (SHA:688314)

SHA:688314 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	324.29	311.71	262.63	229.61	206.31	158.34
Other Revenue	10.23	10.23	12.4	10.34	6.24	5.73
Revenue	334.52	321.95	275.03	239.95	212.55	164.08
Revenue Growth (YoY)	19.34%	17.06%	14.62%	12.89%	29.54%	11.01%
Cost of Revenue	73.15	67.93	60.38	50.19	41.99	32.16
Gross Profit	261.37	254.01	214.65	189.76	170.56	131.92
Selling, General & Admin	119.82	119.76	107.33	91.58	75.18	64.55
Research & Development	23.33	23.9	17.64	18.3	16.8	16.9
Other Operating Expenses	5.65	4.64	4.42	4.03	2.77	1.57
Operating Expenses	148.85	147.96	129.38	114.11	94.71	82.96
Operating Income	112.52	106.05	85.26	75.64	75.85	48.95
Interest Expense	-2.19	-2.17	-1.89	-1.23	-0.74	-0.37
Interest & Investment Income	4.96	5.22	5.2	8.14	4.85	3.12
Currency Exchange Gain (Loss)	-0.37	-0.37	0.23	0.49	0.03	-0.56
Other Non Operating Income (Expenses)	-1.38	-1.75	-0.3	-0.2	-0.17	-0.18
EBT Excluding Unusual Items	113.54	106.98	88.5	82.85	79.82	50.97
Gain (Loss) on Sale of Investments	-13.56	-12.59	-1.86	-	-	-
Gain (Loss) on Sale of Assets	0.44	0.44	-0.06	-0	0.02	-0.02
Asset Writedown	-2.19	-1.87	-	-0.04	-0.35	-0.01
Other Unusual Items	13.05	13.04	5.18	5.66	15.9	7.28
Pretax Income	111.28	106	91.75	88.46	95.39	58.21
Income Tax Expense	19.57	18.37	17.28	14.3	14.21	7.1
Earnings From Continuing Operations	91.71	87.64	74.47	74.16	81.18	51.12
Minority Interest in Earnings	0.8	0.76	1.04	1.53	0.44	1.26
Net Income	92.51	88.4	75.51	75.69	81.63	52.38
Net Income to Common	92.51	88.4	75.51	75.69	81.63	52.38
Net Income Growth	21.68%	17.07%	-0.23%	-7.28%	55.83%	0.86%
Shares Outstanding (Basic)	81	81	81	81	73	61
Shares Outstanding (Diluted)	81	81	81	81	73	61
Shares Change (YoY)	0.38%	-0.12%	-0.23%	11.81%	19.10%	2.55%
EPS (Basic)	1.14	1.09	0.93	0.93	1.12	0.86
EPS (Diluted)	1.14	1.09	0.93	0.93	1.12	0.86
EPS Growth	21.23%	17.20%	-	-17.07%	30.84%	-1.64%
Free Cash Flow	85.19	92.86	71	73.78	48.05	-15.15
Free Cash Flow Per Share	1.05	1.15	0.87	0.91	0.66	-0.25
Dividend Per Share	0.180	0.180	0.320	0.371	0.443	0.371
Dividend Growth	-43.75%	-43.75%	-13.84%	-16.14%	19.25%	-
Gross Margin	78.13%	78.90%	78.05%	79.08%	80.25%	80.40%
Operating Margin	33.64%	32.94%	31.00%	31.52%	35.69%	29.84%
Profit Margin	27.66%	27.46%	27.46%	31.54%	38.40%	31.92%
Free Cash Flow Margin	25.47%	28.84%	25.82%	30.75%	22.61%	-9.23%
EBITDA	123.98	117.29	95.62	85.56	83.02	55.28
EBITDA Margin	37.06%	36.43%	34.77%	35.66%	39.06%	33.69%
D&A For EBITDA	11.45	11.24	10.36	9.91	7.17	6.32
EBIT	112.52	106.05	85.26	75.64	75.85	48.95
EBIT Margin	33.64%	32.94%	31.00%	31.52%	35.69%	29.84%
Effective Tax Rate	17.59%	17.33%	18.83%	16.17%	14.90%	12.19%
Revenue as Reported	334.52	321.95	275.03	239.95	212.55	164.08
Advertising Expenses	-	16.02	17.77	19.97	17.68	15.71

Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.